Novel gel formulations with catanionic aggregates enable prolonged drug release and reduced skin permeation
Corresponding Author
Noel Dew
Noel Dew, co Hud Nordic AB, Box 622, 194 26 Upplands Väsby, Sweden. E-mail: [email protected]Search for more papers by this authorKatarina Edsman
Present address: Q-Med AB, Seminariegatan 21, SE-75228 Uppsala, Sweden.
Search for more papers by this authorErik Björk
Uppsala University, Department of Pharmacy, Uppsala, Sweden
Search for more papers by this authorCorresponding Author
Noel Dew
Noel Dew, co Hud Nordic AB, Box 622, 194 26 Upplands Väsby, Sweden. E-mail: [email protected]Search for more papers by this authorKatarina Edsman
Present address: Q-Med AB, Seminariegatan 21, SE-75228 Uppsala, Sweden.
Search for more papers by this authorErik Björk
Uppsala University, Department of Pharmacy, Uppsala, Sweden
Search for more papers by this authorAbstract
Objectives The aim of this study was to investigate skin permeation rates of a drug substance when applied in novel gel formulations with catanionic aggregates.
Methods Reference gel without catanionic aggregates was compared with formulations with catanionic aggregates composed of tetracaine and either sodium dodecyl sulphate (SDS) or capric acid. Carbomer and SoftCAT were used to compare the effect of different gel types to elucidate if physically cross-linked, ‘self-destructing’ systems had benefits compared with classical, covalently cross-linked, gels.
Key findings The rheological investigation showed that the interactions between the SoftCAT polymer and tetracaine/SDS aggregates were stronger than when the tetracaine/capric acid aggregates were used. The skin permeation was measured ex vivo in horizontal Ussing chambers and the permeation of tetracaine was significantly lower when formulations with tetracaine/SDS aggregates were applied (P < 0.001), but not statistically different from the reference when capric acid was used.
Conclusions No morphological differences could be distinguished between the skin samples exposed to the different formulations or the reference. Skin permeation was compared with silicone sheet permeation and the results indicated that silicone sheets could be used as a model of skin when using these formulations.
References
- 1 Carlfors J et al. Rheological evaluation of Gelrite (R) in situ gels for ophthalmic use. Eur J Pharm Sci 1998; 6: 113–119.
- 2 Edsman K, Hagerstrom H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol 2005; 57: 3–22.
- 3 Bramer T et al. Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels. J Pharm Sci 2006; 95: 769–780.
- 4 Bramer T et al. Effects of pH and ionic strength on catanionic drug-surfactant mixtures used for prolonged release from gels. J Drug Deliv Sci Tec 2007; 17: 285–291.
- 5 Bramer T et al. Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels. Pharm Res 2003; 20: 1661–1667.
- 6 Dew N et al. Catanionic aggregates formed from drugs and lauric or capric acids enable prolonged release from gels. J Colloid Interface Sci 2008; 323: 386–394.
- 7 Dew N et al. Gel formation in systems composed of drug containing catanionic vesicles and oppositely charged hydrophobically modified polymer. Colloids Surf B Biointerfaces 2009; 70: 187–197.
- 8 Paulsson M, Edsman K. Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants. Pharm Res 2001; 18: 1586–1592.
- 9 Bramer T et al. Pharmaceutical applications for catanionic mixtures. J Pharm Pharmacol 2007; 59: 1319–1334.
- 10 Kaler EW et al. Spontaneous vesicle formation in aqueous mixtures of single-tailed surfactants. Science 1989; 245: 1371–1374.
- 11 Tondre C, Caillet C. Properties of the amphiphilic films in mixed cationic/anionic vesicles: a comprehensive view from a literature analysis. Adv Colloid Interface Sci 2001; 93: 115–134.
- 12 Antunes FE et al. Network formation of catanionic vesicles and oppositely charged polyelectrolytes. Effect of polymer charge density and hydrophobic modification. Langmuir 2004; 20: 4647–4656.
- 13 Marques EF et al. Interactions between catanionic vesicles and oppositely charged polyelectrolytes – phase behavior and phase structure. Macromolecules 1999; 32: 6626–6637.
- 14 Ashbaugh HS et al. Gelation of ‘catanionic’ vesicles by hydrophobically modified polyelectrolytes. Colloid Polym Sci 2002; 280: 783–788.
- 15 Lee JH et al. Vesicle-biopolymer gels: networks of surfactant vesicles connected by associating biopolymers. Langmuir 2005; 21: 26–33.
- 16 Medronho B et al. Gels of catanionic vesicles and hydrophobically modified poly(ethylene glycol). J Disper Sci Technol 2006; 27: 83–90.
- 17 Mezei M, Gulasekharam V. Liposomes – a selective drug delivery system for the topical route of administration – gel dosage form. J Pharm Pharmacol 1982; 34: 473–474.
- 18 Michel C et al. Effect of liposomes on percutaneous penetration of lipophilic materials. Int J Pharm 1992; 84: 93–105.
- 19 Wang JL et al. Preparation and pharmaceutical/pharmacodynamic evaluation of topical brucine-loaded liposomal hydrogel. J Mater Sci Mater Med 2009; 20: 2075–2084.
- 20 Maestrelli F et al. Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res 2009; 19: 253–260.
- 21 Michaels AS et al. Drug permeation through human skin – theory and in vitro experimental measurement. AIChE J 1975; 21: 985–996.
- 22 Kirjavainen M et al. Interaction of liposomes with human skin in vitro – the influence of lipid composition and structure. Biochim Biophys Acta 1996; 1304: 179–189.
- 23 Mezei M, Gulasekharam V. Liposomes – a selective drug delivery system for the topical route of administration. 1. Lotion dosage form. Life Sci 1980; 26: 1473–1477.
- 24 Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004; 56: 675–711.
- 25 Maghraby GM et al. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008; 34: 203–222.
- 26 Consola S et al. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery. Chemistry 2007; 13: 3039–3047.
- 27 Östh K et al. Evaluation of drug release from gels on pig nasal mucosa in a horizontal Ussing chamber. J Control Release 2002; 83: 377–388.
- 28 Barbero AM, Frasch HF. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 2009; 23: 1–13.
- 29 Foldvari M et al. Topical dosage form of liposomal tetracaine – effect of additives on the in-vitro release and in-vivo efficacy. J Control Release 1993; 27: 193–205.
- 30 Geinoz S et al. Quantitative structure-permeation relationships for solute transport across silicone membranes. Pharm Res 2002; 19: 1622–1629.
- 31 Hou SYE, Flynn GL. Influences of 1-dodecylazacycloheptan-2-one on permeation of membranes by weak electrolytes. 1. Theoretical analysis of weak electrolyte diffusion through membranes and studies involving silicone rubber membranes. J Pharm Sci 1997; 86: 85–91.
- 32 Vlachy N et al. Determining the cytotoxicity of catanionic surfactant mixtures on HeLa cells. Colloids Surf B Biointerfaces 2009; 70: 278–280.
- 33 Fulmer AW, Kramer GJ. Stratum-corneum lipid abnormalities in surfactant-induced dry scaly skin. J Invest Dermatol 1986; 86: 598–602.
- 34 Hall-Manning TJ et al. Skin irritation potential of mixed surfactant systems. Food Chem Toxicol 1998; 36: 233–238.
- 35 Kabara J. Toxicological, bacteriocidal and fungicidal properties of fatty acids and some derivatives. J Am Oil Chem Soc 1979; 56: 760A–767A.
- 36 Bagley DM et al. Skin irritation: reference chemicals data bank. Toxicol In Vitro 1996; 10: 1–6.
- 37 Wilhelm KP et al. Effect of sodium lauryl sulfate-induced skin irritation on in vivo percutaneous penetration of four drugs. J Invest Dermatol 1991; 97: 927–932.
- 38 Aungst BJ. Structure effect studies of fatty-acid isomers as skin penetration enhancers and skin irritants. Pharm Res 1989; 6: 244–247.
- 39 Aungst BJ et al. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty-acids and amines. Pharm Res 1990; 7: 712–718.
- 40 Chi S-C et al. Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int J Pharm 1995; 126: 267–274.
- 41 Chien YW et al. Transdermal controlled administration of indomethacin. 1. Enhancement of skin permeability. Pharm Res 1988; 5: 103–106.
- 42 Fang C et al. Synergistically enhanced transdermal permeation and topical analgesia of tetracaine gel containing menthol and ethanol in experimental and clinical studies. Eur J Pharm Biopharm 2008; 68: 735–740.
- 43 Fisher R et al. Topical anaesthesia of intact skin: liposome-encapsulated tetracaine vs EMLA. Br J Anaesth 1998; 81: 972–973.
- 44 Woolfson AD et al. Development and characterisation of a moisture-activated bioadhesive drug delivery system for percutaneous local anaesthesia. Int J Pharm 1998; 169: 83–94.
- 45 Zempsky WT, Karasic RB. EMLA versus TAC for topical anesthesia of extremity wounds in children. Ann Emerg Med 1997; 30: 163–166.
- 46 Almdal K et al. Towards a phenomenological definition of the term ‘gel’. Polymer Gels Netw 1993; 1: 5–17.
- 47 Ross-Murphy SB, McEvoy H. Fundamentals of hydrogels and gelation. Brit Polym J 1986; 18: 2–7.
- 48 Higuchi WI. Analysis of data on the medicament release from ointments. J Pharm Sci 1962; 51: 802–804.
- 49 Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987; 5: 23–26.
- 50 Bramer T et al. Implications of regular solution theory on the release mechanism of catanionic mixtures from gels. Colloids Surf B Biointerfaces 2009; 71: 214–225.
- 51 Brohede U et al. Electrodynamic investigations of ion transport and structural properties in drug-containing gels: dielectric spectroscopy and transient current measurements on catanionic carbopol systems. J Phys Chem B 2005; 109: 15250–15255.
- 52
Fartasch M.
Ultrastructure of the epidermal barrier after irritation.
Microsc Res Tech
1997; 37: 193–199.
10.1002/(SICI)1097-0029(19970501)37:3<193::AID-JEMT4>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar